Literature DB >> 8377599

A case of drug-induced ductopenia resulting in fatal biliary cirrhosis.

M Ishii1, Y Miyazaki, T Yamamoto, M Miura, Y Ueno, T Takahashi, T Toyota.   

Abstract

A 50-year-old woman suffered from a diffuse skin rash, high fever and jaundice immediately after a second injection of glutathion and Stronger Neo-minophagen C which contains glycyrrhizin. Liver biopsy performed 11 months after the onset showed mild spotty hepatocyte necrosis, marked cholestasis in parenchyma, and some lymphocyte infiltration in the portal area. Interlobular bile ducts had undergone vacuolar degeneration or were absent in some portal tracts. In her hospital course, unremitting jaundice persisted and biliary cirrhosis developed with signs of portal hypertension; she died from liver failure 26 months after the onset. A liver specimen at her death revealed that most of the interlobular bile ducts had vanished. Based on the clinical course and pathology, drug-induced ductopenia, possibly due to an adverse reaction to glycyrrhizin, is the most likely diagnosis. While drug-related biliary cirrhosis is rarely fatal, this case presented an unusually rapid course of fatal biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377599     DOI: 10.1111/j.1600-0676.1993.tb00635.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury.

Authors:  V A Maria; R M Victorino
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

2.  Bile ductopenia following therapy with sulpiride.

Authors:  D Villari; F Rubino; F Corica; S Spinella; E Di Cesare; G Longo; G Raimondo
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.